Exclusive

Publication

Byline

Location

US Patent Issued on April 21 for "Antibodies targeting integrin beta-2" (Canadian Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,628, issued on April 21. "Antibodies targeting integrin beta-2" was invented by Sachdev Singh Sidhu (Toronto). According to the abstract*... Read More


US Patent Issued to Surrozen Operating on April 21 for "Monospecific anti-frizzled antibodies and methods of use" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,629, issued on April 21, was assigned to Surrozen Operating Inc. (South San Francisco, Calif.). "Monospecific anti-frizzled antibodies and... Read More


US Patent Issued to MONTEFIORE MEDICAL CENTER on April 21 for "CD25 chimeric antigen receptors and uses thereof" (New York Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,630, issued on April 21, was assigned to MONTEFIORE MEDICAL CENTER (Bronx, N.Y.). "CD25 chimeric antigen receptors and uses thereof" was i... Read More


US Patent Issued to REMD Biotherapeutics on April 21 for "Antibodies which bind human endothelin receptor a (ET a R)" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,631, issued on April 21, was assigned to REMD Biotherapeutics Inc (Camarillo, Calif.). "Antibodies which bind human endothelin receptor a ... Read More


US Patent Issued to Apexigen on April 21 for "Anti-CD40 antibodies and methods of use" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,632, issued on April 21, was assigned to Apexigen Inc. (Boston). "Anti-CD40 antibodies and methods of use" was invented by Yongke Zhang (P... Read More


US Patent Issued to SHANGHAI HENLIUS BIOTECH, SHANGHAI HENLIUS BIOPHARMACEUTICAL, SHANGHAI HENLIUS BIOLOGICS on April 21 for "Methods and compositions for anti-CD73 antibodies and variants" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,633, issued on April 21, was assigned to SHANGHAI HENLIUS BIOTECH INC. (Shanghai), SHANGHAI HENLIUS BIOPHARMACEUTICAL Co. LTD. (Shanghai) a... Read More


US Patent Issued to DAIICHI SANKYO on April 21 for "Antibody-pyrrolobenzodiazepine derivative conjugate which binds caludin-6 and claudin-9" (Japanese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,634, issued on April 21, was assigned to DAIICHI SANKYO COMPANY Ltd. (Tokyo). "Antibody-pyrrolobenzodiazepine derivative conjugate which b... Read More


US Patent Issued to Nanjing Legend Biotech on April 21 for "Glypican-2-binding moieties, chimeric antigen receptors and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,635, issued on April 21, was assigned to Nanjing Legend Biotech Co. Ltd. (Nanjing, China). "Glypican-2-binding moieties, chimeric antigen ... Read More


US Patent Issued to Novartis, The Trustees of the University of Pennsylvania on April 21 for "Treatment of cancer using humanized anti-CD19 chimeric antigen receptor" (Massachusetts, Pennsylvania Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,636, issued on April 21, was assigned to Novartis AG (Basel, Switzerland) and The Trustees of the University of Pennsylvania (Philadelphia)... Read More


US Patent Issued to TECHNION RESEARCH & DEVELOPMENT FOUNDATION, HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT on April 21 for "Heparanase-neutralizing A54 monoclonal antibody" (Israeli Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,637, issued on April 21, was assigned to TECHNION RESEARCH & DEVELOPMENT FOUNDATION Ltd. (Haifa, Israel) and HADASIT MEDICAL RESEARCH SERVI... Read More